Gastric Cancer Stem Cells: A Glimpse on Metabolic Reprogramming

被引：14

作者：

Addeo, Martina ^{[1
,2
]}

Di Paola, Giuseppina ^{[1
]}

Verma, Henu Kumar ^{[1
]}

Laurino, Simona ^{[3
,4
]}

Russi, Sabino ^{[4
]}

Zoppoli, Pietro ^{[4
]}

Falco, Geppino ^{[1
,2
,3
,4
]}

Mazzone, Pellegrino ^{[1
]}

机构：

[1] Ist Ric Genet Gaetano Salvatore Biogem Scarl, Ariano Irpino, Italy

[2] Univ Naples Federico II, Dept Biol, Naples, Italy

[3] Inst Expt Endocrinol & Oncol G Salvatore, IEOS CNR, Natl Res Council, Naples, Italy

[4] Referral Canc Ctr Basilicata, Lab Pre Clin & Translat Res, Ist Ricovero Cura Carattere Sci IRCCS, Ctr Riferimento Oncol Basilicata CROB, Rionero In Vulture, Italy

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

gastric cancer; cancer stem cell (CSC); metabolism; reprogramming; therapy; EPITHELIAL-MESENCHYMAL TRANSITION; FATTY-ACID SYNTHASE; HELICOBACTER-PYLORI; LIPID-METABOLISM; PYRUVATE-KINASE; EXPRESSION; PROMOTES; SURVIVAL; OXYGEN; GLUTATHIONE;

D O I：

10.3389/fonc.2021.698394

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gastric cancer (GC) is one of the most widespread causes of cancer-related death worldwide. Recently, emerging implied that gastric cancer stem cells (GCSCs) play an important role in the initiation and progression of GC. This subpopulation comprises cells with several features, such as self-renewal capability, high proliferating rate, and ability to modify their metabolic program, which allow them to resist current anticancer therapies. Metabolic pathway intermediates play a pivotal role in regulating cell differentiation both in tumorigenesis and during normal development. Thus, the dysregulation of both anabolic and catabolic pathways constitutes a significant opportunity to target GCSCs in order to eradicate the tumor progression. In this review, we discuss the current knowledge about metabolic phenotype that supports GCSC proliferation and we overview the compounds that selectively target metabolic intermediates of CSCs that can be used as a strategy in cancer therapy.

引用

页数：13

共 130 条

[1] Cancer stem cells as key drivers of tumour progression [J].

Ayob, Ain Zubaidah ;

Ramasamy, Thamil Selvee .

JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25

[2] Increased expression of miR-146a, miR-10b, and miR-21 in cancer stem-like gastro-spheres [J].

Bakhshi, Mahdieh ;

Asadi, Jahanbakhsh ;

Ebrahimi, Marzieh ;

Moradi, Abdol-Vahab ;

Hajimoradi, Monireh .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) :16589-16599

[3]

Bao B, 2014, CURR STEM CELL RES T, V9, P22

[4]

Bao Bin, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1425s61

[5] Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis [J].

Basati, Gholam ;

Mohammadpour, Hadiseh ;

Emami Razavi, Amirnader .

JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (01) :41-47

[6] Identifying and targeting cancer stem cells in the treatment of gastric cancer [J].

Bekaii-Saab, Tanios ;

El-Rayes, Bassel .

CANCER, 2017, 123 (08) :1303-1312

[7] Stem cells and the impact of ROS signaling [J].

Bigarella, Carolina L. ;

Liang, Raymond ;

Ghaffari, Saghi .

DEVELOPMENT, 2014, 141 (22) :4206-4218

[8] Risk factors for gastric cancer in Latin America: a meta-analysis [J].

Bonequi, Patricia ;

Meneses-Gonzalez, Fernando ;

Correa, Pelayo ;

Rabkin, Charles S. ;

Constanza Camargo, M. .

CANCER CAUSES & CONTROL, 2013, 24 (02) :217-231

[9] Mechanism of p38 MAP kinase activation in vivo [J].

Brancho, D ;

Tanaka, N ;

Jaeschke, A ;

Ventura, JJ ;

Kelkar, N ;

Tanaka, Y ;

Kyuuma, M ;

Takeshita, T ;

Flavell, RA ;

Davis, RJ .

GENES & DEVELOPMENT, 2003, 17 (16) :1969-1978

[10]

Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23

← 1 2 3 4 5 6 7 8 9 10 →